Kuikui Zhang

Dr. Kuikui Zhang


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2026 in Micro
Verified
Journal Article
Open access
PDF file
KZKuikui Zhang
Kuikui Zhang
FLFang Lezhou
Fang Lezhou
CXcan xu
can xu
WZWeiwei Zhou
Weiwei Zhou
XDXiaoqiu Deng
Xiaoqiu Deng
LPLijia Pan
Lijia Pan
Regenerative medicine is increasingly leveraging the synergies between bioinspired conductive biomaterials and 3D/4D bioprinting to replicate the native electroactive and hierarchical microenvironments essential for functional tissue restoration. However, a critical gap remains in the intelligent integration of these technologies to achieve dynamic, responsive tissue regeneration. This review introduces a “bioinspired material–printing–function” triad framework to systematically synthesize recent advances in: (1) tunable conductive materials (polymers, carbon-based systems, metals, MXenes) designed to mimic the electrophysiological properties of native tissues; (2) advanced 3D/4D printing technologies (vat photopolymerization, extrusion, inkjet, and emerging modalities) enabling the fabrication of biomimetic architectures; and (3) functional applications in neural, cardiac, and musculoskeletal tissue engineering. We highlight how bioinspired conductive scaffolds enhance electrophysiological behaviors—emulating natural processes such as promoting axon regeneration cardiomyocyte synchronization, and osteogenic mineralization. Crucially, we identify multi-material 4D bioprinting as a transformative bioinspired approach to overcome conductivity–degradation trade-offs and enable shape-adaptive, smart scaffolds that dynamically respond to physiological cues, mirroring the adaptive nature of living tissues. This work provides the first roadmap toward intelligent electroactive regeneration, shifting the paradigm from static implants to dynamic, biomimetic bioelectronic microenvironments. Future translation will require leveraging AI-driven bioinspired design and organ-on-a-chip validation to address challenges in vascularization, biosafety, and clinical scalability.